Lund, Sweden

Tomas Landh

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 97(Granted Patents)


Company Filing History:


Years Active: 1996-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Tomas Landh

Introduction

Tomas Landh is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceutical compositions, particularly in nicotine replacement therapy. With a total of 2 patents, his work focuses on enhancing the delivery and absorption of nicotine through innovative formulations.

Latest Patents

Tomas Landh's latest patents include "Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption" and "Particles, method of preparing said particles and uses thereof." The first patent details formulations of nicotine intended for application in the oral cavity, where the uptake of nicotine primarily occurs through the buccal mucosa. These formulations consist of apolar, polar, and surface-active components, and may be administered in combination with other nicotine formulations. The second patent focuses on the preparation of specific particles and their various applications.

Career Highlights

Throughout his career, Tomas Landh has worked with prominent companies such as Gs Biochem AB and Pharmacia AB. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Tomas has collaborated with notable individuals in his field, including Kare V. Larsson and Sven Börje Andersson. Their joint efforts have further advanced the development of nicotine-related pharmaceutical products.

Conclusion

Tomas Landh's contributions to nicotine replacement therapy through his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to influence the development of effective nicotine delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…